Pipeline

August 23, 2021
Company Drug/Device Medical Condition Status
Novatek Pharmaceuticals TQ Formula oral treatment for COVID-19 patients in an outpatient setting IND approved by the FDA
Occlutech Flex II PFO occluder patients with cryptogenic stroke Investigational Device Exemption approved by the FDA
Angel Pharmaceuticals CPI-818 relapsed/refractory T-cell lymphomas IND approved by the China National Medical Products Administration
Enlivex Therapeutics Allocetra treatment of patients with severe and critical COVID-19 experiencing acute respiratory distressed syndrome authorization granted by the Israeli Ministry of Health for a phase 2b trial
Istari Oncology PVSRIPO head and neck squamous-cell carcinoma initiation of phase 1/2 substudy
Turning Point Therapeutics repotrectinib in combination with trametinib RAS G12D-mutated advanced solid tumors initiation of phase 1b/2 trial
Trigone Pharma TRG-100 interstitial cystitis/ bladder pain syndrome initiation of phase 2 trial
Cali Biosciences CPL-01 (extended-release injectable ropivacaine hydrochloride) long-acting postoperative analgesic initiation of phase 2b trial
Pfizer-BioNTech COVID-19 Vaccine COVID-19 Emergency Use Authorization (EUA) amended to include an additional shot in certain immunocompromised people
Moderna COVID-19 Vaccine COVID-19 EUA amended to include an additional shot in certain immunocompromised people
Spectrum Solutions SDNA-1000 saliva collection device at-home COVID-19 testing EUA amended to include the unsupervised self-collection of saliva
Eli Lilly Lyumjev (insulin lispro-aabc injection) subcutaneous pump glycemic control in adults with type 1 and type 2 diabetes approved by the FDA for expanded administration
GlaxoSmithKline Jemperli (dostarlimab) adults with dMMR recurrent or advanced solid tumors approved by the FDA for expanded indication
Jazz Pharmaceuticals Xywav (calcium, magnesium, potassium and sodium oxybates) oral solution idiopathic hypersomnia approved by the FDA for new indication
Merck Welireg (belzutifan) treatment of adult patients with certain types of Von Hippel-Lindau disease-associated tumors approved by the FDA
Pfizer Ticovac tick-borne encephalitis (TBE) vaccine active immunization to prevent TBE in individuals age one year and older approved by the FDA
GC Pharma GreenGene F (beroctocog alfa) recombinant human coagulation factor VIII for injection control and prophylaxis of bleeding episodes in patients with hemophilia A approved in China
Nasus Pharma Taffix intranasal powder viral infections approved in Spain
Photocure Hexvix (hexaminolevulinate HCl) management of bladder cancer approved in Chile

 

Upcoming Events

Featured Products

Featured Stories

Standard Operating Procedures for Risk-Based Monitoring of Clinical Trials

The information you need to adapt your monitoring plan to changing times.

Learn More Here